Growth factor independence 1 (Gfi1) as a regulator of lymphocyte development and activation

Seminars in Immunology

Volumn 23, Issue 5, 2011, Pages 368-378

  Möröy, Tarik ^a,b   Khandanpour, Cyrus ^a,c  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

B cell development; CD4; CD8; Gfi1; Il 7R; Mouse; T cell development; Th17; Th2; Transcription factor; Treg

Indexed keywords

DNA BINDING PROTEIN; GROWTH FACTOR INDEPENDENCE 1; HISTONE H3; IKAROS TRANSCRIPTION FACTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR; INTERLEUKIN 7 RECEPTOR ALPHA; JANUS KINASE 1; MESSENGER RNA; NOTCH1 RECEPTOR; OX40 LIGAND; P21 ACTIVATED KINASE 1; PROTEIN BAK; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN CDC42; STAT5 PROTEIN; STEM CELL FACTOR RECEPTOR; THY 1 ANTIGEN; TRANSCRIPTION FACTOR E2A; TRANSCRIPTION FACTOR EGR 1; TRANSCRIPTION FACTOR PAX5; TRANSCRIPTION FACTOR PU 1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZINC FINGER PROTEIN;

AUTOIMMUNITY; B LYMPHOCYTE; BINDING SITE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINEAGE; CELL MATURATION; CELL MIGRATION; CELL SELECTION; CELL SURVIVAL; DENDRITIC CELL; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; GENE REPRESSION; HISTONE MODIFICATION; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; LYMPHATIC LEUKEMIA; LYMPHOID PROGENITOR CELL; LYMPHOMA; LYMPHOPOIESIS; MOLECULAR DOCKING; MULTIPOTENT STEM CELL; NATURAL KILLER CELL; NONHUMAN; POLARIZATION; PRE T LYMPHOCYTE; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW; RNA SPLICING; SIGNAL TRANSDUCTION; TH17 CELL; THYMOCYTE;

ANIMALS; B-LYMPHOCYTES; DNA-BINDING PROTEINS; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOPOIESIS; MICE; MODELS, BIOLOGICAL; T-LYMPHOCYTES; TRANSCRIPTION FACTORS;

EID: 82555164922     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2011.08.006     Document Type: Review

References (118)

1. Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature 2007, 449:819-826.
2. Iwasaki A., Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science 2010, 327:291-295.
3. Carpenter A.C., Bosselut R. Decision checkpoints in the thymus. Nat Immunol 2010, 11:666-673.
4. Welner R.S., Pelayo R., Kincade P.W. Evolving views on the genealogy of B cells. Nat Rev Immunol 2008, 8:95-106.
5. Hale J.S., Fink P.J. T-cell receptor revision: friend or foe?. Immunology. 2010, 129:467-473.
6. Matthews A.G., Oettinger M.A. RAG: a recombinase diversified. Nat Immunol 2009, 10:817-821.
7. Li Z., Woo C.J., Iglesias-Ussel M.D., Ronai D., Scharff M.D. The generation of antibody diversity through somatic hypermutation and class switch recombination. Genes Dev 2004, 18:1-11.
8. Harkiolaki M., Holmes S.L., Svendsen P., Gregersen J.W., Jensen L.T., McMahon R., et al. T cell-mediated autoimmune disease due to low-affinity crossreactivity to common microbial peptides. Immunity 2009, 30:348-357.
9. Shlomchik M.J. Activating systemic autoimmunity: B's, T's, and tolls. Curr Opin Immunol 2009, 21:626-633.
10. Karsunky H., Zeng H., Schmidt T., Zevnik B., Kluge R., Schmid K.W., et al. Inflammatory reactions and severe neutropenia in mice lacking the transcriptional repressor Gfi1. Nat Genet 2002, 30:295-300.
11. Hock H., Hamblen M.J., Rooke H.M., Traver D., Bronson R.T., Cameron S., et al. Intrinsic requirement for zinc finger transcription factor Gfi-1 in neutrophil differentiation. Immunity 2003, 18:109-120.
12. Yucel R., Karsunky H., Klein-Hitpass L., Moroy T. The transcriptional repressor Gfi1 affects development of early, uncommitted c-Kit+ T cell progenitors and CD4/CD8 lineage decision in the thymus. J Exp Med 2003, 197:831-844.
13. Hock H., Hamblen M.J., Rooke H.M., Schindler J.W., Saleque S., Fujiwara Y., et al. Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells. Nature 2004, 431:1002-1007.
14. Yucel R., Kosan C., Heyd F., Moroy T. Gfi1:green fluorescent protein knock-in mutant reveals differential expression and autoregulation of the growth factor independence 1 (Gfi1) gene during lymphocyte development. J Biol Chem 2004, 279:40906-40917.
15. Zeng H., Yucel R., Kosan C., Klein-Hitpass L., Moroy T. Transcription factor Gfi1 regulates self-renewal and engraftment of hematopoietic stem cells. EMBO J 2004, 23:4116-4125.
16. Pargmann D., Yucel R., Kosan C., Saba I., Klein-Hitpass L., Schimmer S., et al. Differential impact of the transcriptional repressor Gfi1 on mature CD4+ and CD8+ T lymphocyte function. Eur J Immunol 2007, 37:3551-3563.
17. Ichiyama K., Hashimoto M., Sekiya T., Nakagawa R., Wakabayashi Y., Sugiyama Y., et al. Gfi1 negatively regulates T(h)17 differentiation by inhibiting RORgammat activity. Int Immunol 2009, 21:881-889.
18. Sharif-Askari E., Vassen L., Kosan C., Khandanpour C., Gaudreau M.C., Heyd F., et al. Zinc finger protein Gfi1 controls the endotoxin-mediated Toll-like receptor inflammatory response by antagonizing NF-kappaB p65. Mol Cell Biol 2010, 30:3929-3942.
19. Person R.E., Li F.Q., Duan Z., Benson K.F., Wechsler J., Papadaki H.A., et al. Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2. Nat Genet 2003, 34:308-312.
20. Horman S.R., Velu C.S., Chaubey A., Bourdeau T., Zhu J., Paul W.E., et al. Gfi1 integrates progenitor versus granulocytic transcriptional programming. Blood 2009.
21. Liu Y., Elf S.E., Miyata Y., Sashida G., Huang G., Di Giandomenico S., et al. p53 regulates hematopoietic stem cell quiescence. Cell Stem Cell 2009, 4:37-48.
22. Velu C.S., Baktula A.M., Grimes H.L. Gfi1 regulates miR-21 and miR-196b to control myelopoiesis. Blood 2009, 113:4720-4728.
23. Li H., Ji M., Klarmann K.D., Keller J.R. Repression of Id2 expression by Gfi-1 is required for B cell and myeloid development. Blood 2010.
24. Park J.H., Yu Q., Erman B., Appelbaum J.S., Montoya-Durango D., Grimes H.L., et al. Suppression of IL7Ralpha transcription by IL-7 and other prosurvival cytokines: a novel mechanism for maximizing IL-7-dependent T cell survival. Immunity 2004, 21:289-302.
25. Fiolka K., Hertzano R., Vassen L., Zeng H., Hermesh O., Avraham K.B., et al. Gfi1 and Gfi1b act equivalently in haematopoiesis, but have distinct, non-overlapping functions in inner ear development. EMBO Rep 2006, 7:326-333.
26. Zhu J., Jankovic D., Grinberg A., Guo L., Paul W.E. Gfi-1 plays an important role in IL-2-mediated Th2 cell expansion. Proc Natl Acad Sci USA 2006, 103:18214-18219.
27. Spooner C.J., Cheng J.X., Pujadas E., Laslo P., Singh H. A recurrent network involving the transcription factors PU.1 and Gfi1 orchestrates innate and adaptive immune cell fates. Immunity 2009, 31:576-586.
28. Zhu J., Davidson T.S., Wei G., Jankovic D., Cui K., Schones D.E., et al. Down-regulation of Gfi-1 expression by TGF-beta is important for differentiation of Th17 and CD103+ inducible regulatory T cells. J Exp Med 2009, 206:329-341.
29. Phelan J.D., Shroyer N.F., Cook T., Gebelein B., Grimes H.L. Gfi1-cells and circuits: unraveling transcriptional networks of development and disease. Curr Opin Hematol 2010, 17:300-307.
30. Gilks C.B., Bear S.E., Grimes H.L., Tsichlis P.N. Progression of interleukin-2 (IL-2)-dependent rat T cell lymphoma lines to IL-2-independent growth following activation of a gene (Gfi-1) encoding a novel zinc finger protein. Mol Cell Biol 1993, 13:1759-1768.
31. Bell D.W., Taguchi T., Jenkins N.A., Gilbert D.J., Copeland N.G., Gilks C.B., et al. Chromosomal localization of a gene, GF1, encoding a novel zinc finger protein reveals a new syntenic region between man and rodents. Cytogenet Cell Genet 1995, 70:263-267.
32. Grimes H.L., Chan T.O., Zweidler-McKay P.A., Tong B., Tsichlis P.N. The Gfi-1 proto-oncoprotein contains a novel transcriptional repressor domain, SNAG, and inhibits G1 arrest induced by interleukin-2 withdrawal. Mol Cell Biol 1996, 16:6263-6272.
33. Zweidler-Mckay P.A., Grimes H.L., Flubacher M.M., Tsichlis P.N. Gfi-1 encodes a nuclear zinc finger protein that binds DNA and functions as a transcriptional repressor. Mol Cell Biol 1996, 16:4024-4034.
34. Duan Z., Horwitz M. Targets of the transcriptional repressor oncoprotein Gfi-1. Proc Natl Acad Sci USA 2003, 100:5932-5937.
35. Duan Z., Zarebski A., Montoya-Durango D., Grimes H.L., Horwitz M. Gfi1 coordinates epigenetic repression of p21Cip/WAF1 by recruitment of histone lysine methyltransferase G9a and histone deacetylase 1. Mol Cell Biol 2005, 25:10338-10351.
36. Saleque S., Kim J., Rooke H.M., Orkin S.H. Epigenetic regulation of hematopoietic differentiation by Gfi-1 and Gfi-1b is mediated by the cofactors CoREST and LSD1. Mol Cell 2007, 27:562-572.
37. Montoya-Durango D.E., Velu C.S., Kazanjian A., Rojas M.E., Jay C.M., Longmore G.D., et al. Ajuba functions as a histone deacetylase-dependent co-repressor for autoregulation of the growth factor-independent-1 transcription factor. J Biol Chem 2008, 283:32056-32065.
38. Marteijn J.A., van der Meer L.T., van Emst L., van Reijmersdal S., Wissink W., de Witte T., et al. Gfi1 ubiquitination and proteasomal degradation is inhibited by the ubiquitin ligase Triad1. Blood 2007, 110:3128-3135.
39. Khanna-Gupta A., Sun H., Zibello T., Lee H.M., Dahl R., Boxer L.A., et al. Growth factor independence-1 (Gfi-1) plays a role in mediating specific granule deficiency (SGD) in a patient lacking a gene-inactivating mutation in the C/EBPepsilon gene. Blood 2007, 109:4181-4190.
40. de la Luz Sierra M., Sakakibara S., Gasperini P., Salvucci O., Jiang K., McCormick P.J., et al. The transcription factor Gfi1 regulates G-CSF signaling and neutrophil development through the Ras activator RasGRP1. Blood 2010, 115:3970-3979.
41. Rodel B., Tavassoli K., Karsunky H., Schmidt T., Bachmann M., Schaper F., et al. The zinc finger protein Gfi-1 can enhance STAT3 signaling by interacting with the STAT3 inhibitor PIAS3. EMBO J 2000, 19:5845-5855.
42. Nakagawa K., Yokosawa H. PIAS3 induces SUMO-1 modification and transcriptional repression of IRF-1. FEBS Lett 2002, 530:204-208.
43. Matsuura T., Shimono Y., Kawai K., Murakami H., Urano T., Niwa Y., et al. PIAS proteins are involved in the SUMO-1 modification, intracellular translocation and transcriptional repressive activity of RET finger protein. Exp Cell Res 2005, 308:65-77.
44. Khandanpour C., Thiede C., Valk P.J., Sharif-Askari E., Nuckel H., Lohmann D., et al. A variant allele of Growth Factor Independence 1 (GFI1) is associated with acute myeloid leukemia. Blood 2010, 115:2462-2472.
45. Vassen L., Khandanpour C., Ebeling P., van der Reijden B.A., Jansen J.H., Mahlmann S., et al. Growth factor independent 1b (Gfi1b) and a new splice variant of Gfi1b are highly expressed in patients with acute and chronic leukemia. Int J Hematol 2009, 89:422-430.
46. van der Meer L.T., Jansen J.H., van der Reijden B.A. Gfi1 and Gfi1b: key regulators of hematopoiesis. Leukemia 2010.
47. Hardy R.R., Shinton S.A. Characterization of B lymphopoiesis in mouse bone marrow and spleen. Methods Mol Biol 2004, 271:1-24.
48. Rolink A.G., ten Boekel E., Yamagami T., Ceredig R., Andersson J., Melchers F. B cell development in the mouse from early progenitors to mature B cells. Immunol Lett 1999, 68:89-93.
49. Morrison S.J., Weissman I.L. The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity 1994, 1:661-673.
50. Christensen J.L., Weissman I.L. Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells. Proc Natl Acad Sci USA 2001, 98:14541-14546.
51. Adolfsson J., Mansson R., Buza-Vidas N., Hultquist A., Liuba K., Jensen C.T., et al. Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential a revised road map for adult blood lineage commitment. Cell 2005, 121:295-306.
52. Mansson R., Hultquist A., Luc S., Yang L., Anderson K., Kharazi S., et al. Molecular evidence for hierarchical transcriptional lineage priming in fetal and adult stem cells and multipotent progenitors. Immunity 2007, 26:407-419.
53. Igarashi H., Gregory S.C., Yokota T., Sakaguchi N., Kincade P.W. Transcription from the RAG1 locus marks the earliest lymphocyte progenitors in bone marrow. Immunity 2002, 17:117-130.
54. Allman D., Sambandam A., Kim S., Miller J.P., Pagan A., Well D., et al. Thymopoiesis independent of common lymphoid progenitors. Nat Immunol 2003, 4:168-174.
55. Kondo M., Weissman I.L., Akashi K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 1997, 91:661-672.
56. Sitnicka E., Brakebusch C., Martensson I.L., Svensson M., Agace W.W., Sigvardsson M., et al. Complementary signaling through flt3 and interleukin-7 receptor alpha is indispensable for fetal and adult B cell genesis. J Exp Med 2003, 198:1495-1506.
57. Rathinam C., Lassmann H., Mengel M., Klein C. Transcription factor Gfi1 restricts B cell-mediated autoimmunity. J Immunol 2008, 181:6222-6229.
58. Peschon J.J., Morrissey P.J., Grabstein K.H., Ramsdell F.J., Maraskovsky E., Gliniak B.C., et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med 1994, 180:1955-1960.
59. Horowitz M.C., Bothwell A.L., Hesslein D.G., Pflugh D.L., Schatz D.G. B cells and osteoblast and osteoclast development. Immunol Rev 2005, 208:141-153.
60. Miller J.P., Izon D., DeMuth W., Gerstein R., Bhandoola A., Allman D. The earliest step in B lineage differentiation from common lymphoid progenitors is critically dependent upon interleukin 7. J Exp Med 2002, 196:705-711.
61. Namen A.E., Lupton S., Hjerrild K., Wignall J., Mochizuki D.Y., Schmierer A., et al. Stimulation of B-cell progenitors by cloned murine interleukin-7. Nature 1988, 333:571-573.
62. Kikuchi K., Lai A.Y., Hsu C.L., Kondo M. IL-7 receptor signaling is necessary for stage transition in adult B cell development through up-regulation of EBF. J Exp Med 2005, 201:1197-1203.
63. O'Riordan M., Grosschedl R. Coordinate regulation of B cell differentiation by the transcription factors EBF and E2A. Immunity 1999, 11:21-31.
64. Malin S., McManus S., Cobaleda C., Novatchkova M., Delogu A., Bouillet P., et al. Role of STAT5 in controlling cell survival and immunoglobulin gene recombination during pro-B cell development. Nat Immunol 2010, 11:171-179.
65. Lin H., Grosschedl R. Failure of B-cell differentiation in mice lacking the transcription factor EBF. Nature 1995, 376:263-267.
66. Nutt S.L., Urbanek P., Rolink A., Busslinger M. Essential functions of Pax5 (BSAP) in pro-B cell development: difference between fetal and adult B lymphopoiesis and reduced V-to-DJ recombination at the IgH locus. Genes Dev 1997, 11:476-491.
67. Urbanek P., Wang Z.Q., Fetka I., Wagner E.F., Busslinger M. Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell 1994, 79:901-912.
68. Chandele A., Joshi N.S., Zhu J., Paul W.E., Leonard W.J., Kaech S.M. Formation of IL-7Ralphahigh and IL-7Ralphalow CD8 T cells during infection is regulated by the opposing functions of GABPalpha and Gfi-1. J Immunol 2008, 180:5309-5319.
69. Medina K.L., Singh H. Genetic networks that regulate B lymphopoiesis. Curr Opin Hematol 2005, 12:203-209.
70. Ramirez J., Lukin K., Hagman J. From hematopoietic progenitors to B cells: mechanisms of lineage restriction and commitment. Curr Opin Immunol 2010, 22:177-184.
71. Dias S., Mansson R., Gurbuxani S., Sigvardsson M., Kee B.L. E2A proteins promote development of lymphoid-primed multipotent progenitors. Immunity 2008, 29:217-227.
72. Friedman A.D. Transcriptional control of granulocyte and monocyte development. Oncogene 2007, 26:6816-6828.
73. Wilson N.K., Timms R.T., Kinston S.J., Cheng Y.H., Oram S.H., Landry J.R., et al. Gfi1 expression is controlled by five distinct regulatory regions spread over 100 kilobases, with Scl/Tal1, Gata2, PU.1, Erg, Meis1, and Runx1 acting as upstream regulators in early hematopoietic cells. Mol Cell Biol 2010, 30:3853-3863.
74. Dahl R., Iyer S.R., Owens K.S., Cuylear D.D., Simon M.C. The transcriptional repressor GFI-1 antagonizes PU.1 activity through protein-protein interaction. J Biol Chem 2007, 282:6473-6483.
75. Li H., Ji M., Klarmann K.D., Keller J.R. Repression of Id2 expression by Gfi-1 is required for B-cell and myeloid development. Blood 2010, 116:1060-1069.
76. Rathinam C., Klein C. Transcriptional repressor Gfi1 integrates cytokine-receptor signals controlling B-cell differentiation. PLoS One 2007, 2:e306.
77. Kenter A.L. Class switch recombination: an emerging mechanism. Curr Top Microbiol Immunol 2005, 290:171-199.
78. Dudley D.D., Chaudhuri J., Bassing C.H., Alt F.W. Mechanism and control of V(D)J recombination versus class switch recombination: similarities and differences. Adv Immunol 2005, 86:43-112.
79. Luo Z., Ronai D., Scharff M.D. The role of activation-induced cytidine deaminase in antibody diversification, immunodeficiency, and B-cell malignancies. J Allergy Clin Immunol 2004, 114:726-735. quiz 736.
80. Muramatsu M., Kinoshita K., Fagarasan S., Yamada S., Shinkai Y., Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000, 102:553-563.
81. Igwe E., Kosan C., Khandanpour C., Sharif-Askari E., Brune B., Moroy T. The zinc finger protein Gfi1 is implicated in the regulation of IgG2b production and the expression of Igamma2b germline transcripts. Eur J Immunol 2008, 38:3004-3014.
82. Park S.R., Seo G.Y., Choi A.J., Stavnezer J., Kim P.H. Analysis of transforming growth factor-beta1-induced Ig germ-line gamma2b transcription and its implication for IgA isotype switching. Eur J Immunol 2005, 35:946-956.
83. Snapper C.M., Waegell W., Beernink H., Dasch J.R. Transforming growth factor-beta 1 is required for secretion of IgG of all subclasses by LPS-activated murine B cells in vitro. J Immunol 1993, 151:4625-4636.
84. Boehm T., Bleul C.C. Thymus-homing precursors and the thymic microenvironment. Trends Immunol 2006, 27:477-484.
85. Heinzel K., Benz C., Martins V.C., Haidl I.D., Bleul C.C. Bone marrow-derived hemopoietic precursors commit to the T cell lineage only after arrival in the thymic microenvironment. J Immunol 2007, 178:858-868.
86. Benz C., Bleul C.C. A multipotent precursor in the thymus maps to the branching point of the T versus B lineage decision. J Exp Med 2005, 202:21-31.
87. Sambandam A., Maillard I., Zediak V.P., Xu L., Gerstein R.M., Aster J.C., et al. Notch signaling controls the generation and differentiation of early T lineage progenitors. Nat Immunol 2005, 6:663-670.
88. Bolotin E., Smogorzewska M., Smith S., Widmer M., Weinberg K. Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7. Blood 1996, 88:1887-1894.
89. Radtke F., Wilson A., Stark G., Bauer M., van Meerwijk J., MacDonald H.R., et al. Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity 1999, 10:547-558.
90. Wang L., Xiong Y., Bosselut R. Tenuous paths in unexplored territory: from T cell receptor signaling to effector gene expression during thymocyte selection. Semin Immunol 2010, 22:294-302.
91. Vicente R., Swainson L., Marty-Gres S., De Barros S.C., Kinet S., Zimmermann V.S., et al. Molecular and cellular basis of T cell lineage commitment. Semin Immunol 2010, 22:270-275.
92. Awong G., LaMotte-Mohs R., Zuniga-Pflucker J.C. Key players for T-cell regeneration. Curr Opin Hematol 2010, 17:327-332.
93. Dervovic D., Zuniga-Pflucker J.C. Positive selection of T cells, an in vitro view. Semin Immunol 2010, 22:276-286.
94. Holmes R., Zuniga-Pflucker J.C. The OP9-DL1 system: generation of T-lymphocytes from embryonic or hematopoietic stem cells in vitro. Cold Spring Harb Protoc 2009, 2009. pdb prot5156.
95. Zuniga-Pflucker J.C. The original intrathymic progenitor from which T cells originate. J Immunol 2009, 183:3-4.
96. Zuniga-Pflucker J.C., van den Brink M.R. Giving T cells a chance to come back. Semin Immunol 2007, 19:279.
97. Michie A.M., Chan A.C., Ciofani M., Carleton M., Lefebvre J.M., He Y., et al. Constitutive Notch signalling promotes CD4 CD8 thymocyte differentiation in the absence of the pre-TCR complex, by mimicking pre-TCR signals. Int Immunol 2007, 19:1421-1430.
98. von Freeden-Jeffry U., Solvason N., Howard M., Murray R. The earliest T lineage-committed cells depend on IL-7 for Bcl-2 expression and normal cell cycle progression. Immunity 1997, 7:147-154.
99. Jiang Q., Li W.Q., Aiello F.B., Mazzucchelli R., Asefa B., Khaled A.R., et al. Cell biology of IL-7, a key lymphotrophin. Cytokine Growth Factor Rev 2005, 16:513-533.
100. Ciofani M., Zuniga-Pflucker J.C. A survival guide to early T cell development. Immunol Res 2006, 34:117-132.
101. Jiang Q., Li W.Q., Hofmeister R.R., Young H.A., Hodge D.R., Keller J.R., et al. Distinct regions of the interleukin-7 receptor regulate different Bcl2 family members. Mol Cell Biol 2004, 24:6501-6513.
102. Qin J.Z., Zhang C.L., Kamarashev J., Dummer R., Burg G., Dobbeling U. Interleukin-7 and interleukin-15 regulate the expression of the bcl-2 and c-myb genes in cutaneous T-cell lymphoma cells. Blood 2001, 98:2778-2783.
103. Weber-Nordt R.M., Egen C., Wehinger J., Ludwig W., Gouilleux-Gruart V., Mertelsmann R., et al. Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines. Blood 1996, 88:809-816.
104. Yasukawa H., Sasaki A., Yoshimura A. Negative regulation of cytokine signaling pathways. Annu Rev Immunol 2000, 18:143-164.
105. Wofford J.A., Wieman H.L., Jacobs S.R., Zhao Y., Rathmell J.C. IL-7 promotes Glut1 trafficking and glucose uptake via STAT5-mediated activation of Akt to support T-cell survival. Blood 2008, 111:2101-2111.
106. Guo F., Hildeman D., Tripathi P., Velu C.S., Grimes H.L., Zheng Y. Coordination of IL-7 receptor and T-cell receptor signaling by cell-division cycle 42 in T-cell homeostasis. Proc Natl Acad Sci USA 2010.
107. Schmidt T., Karsunky H., Rodel B., Zevnik B., Elsasser H.P., Moroy T. Evidence implicating Gfi-1 and Pim-1 in pre-T-cell differentiation steps associated with beta-selection. EMBO J 1998, 17:5349-5359.
108. Grimes H.L., Gilks C.B., Chan T.O., Porter S., Tsichlis P.N. The Gfi-1 protooncoprotein represses Bax expression and inhibits T-cell death. Proc Natl Acad Sci USA 1996, 93:14569-14573.
109. Doan L.L., Porter S.D., Duan Z., Flubacher M.M., Montoya D., Tsichlis P.N., et al. Targeted transcriptional repression of Gfi1 by GFI1 and GFI1B in lymphoid cells. Nucleic Acids Res 2004, 32:2508-2519.
110. Liu Q., Basu S., Qiu Y., Tang F., Dong F. A role of Miz-1 in Gfi-1-mediated transcriptional repression of CDKN1A. Oncogene 2010, 29:2843-2852.
111. Basu S., Liu Q., Qiu Y., Dong F. Gfi-1 represses CDKN2B encoding p15INK4B through interaction with Miz-1. Proc Natl Acad Sci USA 2009, 106:1433-1438.
112. Nakazawa Y., Suzuki M., Manabe N., Yamada T., Kihara-Negishi F., Sakurai T., et al. Cooperative interaction between ETS1 and GFI1 transcription factors in the repression of Bax gene expression. Oncogene 2007, 26:3541-3550.
113. Singer A., Adoro S., Park J.H. Lineage fate and intense debate: myths, models and mechanisms of CD4- versus CD8-lineage choice. Nat Rev Immunol 2008, 8:788-801.
114. Benoit A., Abdkader K., Sirskyj D., Alhetheel A., Sant N., Diaz-Mitoma F., et al. Inverse association of repressor growth factor independent-1 with CD8 T cell interleukin (IL)-7 receptor [alpha] expression and limited signal transducers and activators of transcription signaling in response to IL-7 among [gamma]-chain cytokines in HIV patients. AIDS 2009, 23:1341-1347.
115. Heyd F., ten Dam G., Moroy T. Auxiliary splice factor U2AF26 and transcription factor Gfi1 cooperate directly in regulating CD45 alternative splicing. Nat Immunol 2006, 7:859-867.
116. Zhu J., Guo L., Min B., Watson C.J., Hu-Li J., Young H.A., et al. Growth factor independent-1 induced by IL-4 regulates Th2 cell proliferation. Immunity 2002, 16:733-744.
117. Shinnakasu R., Yamashita M., Kuwahara M., Hosokawa H., Hasegawa A., Motohashi S., et al. Gfi1-mediated stabilization of GATA3 protein is required for Th2 cell differentiation. J Biol Chem 2008, 283:28216-28225.
118. Zhu J., Yamane H., Cote-Sierra J., Guo L., Paul W.E. GATA-3 promotes Th2 responses through three different mechanisms: induction of Th2 cytokine production, selective growth of Th2 cells and inhibition of Th1 cell-specific factors. Cell Res 2006, 16:3-10.